Mitochondria Biology: Energy, Signalling, and Disease

Introduction to Mitochondria

Mitochondria are double-membrane organelles performing oxidative phosphorylation generating the majority of cellular ATP, but their functions extend far beyond energy production. Mitochondria regulate calcium homeostasis buffering cytoplasmic Ca2+ spikes, produce reactive oxygen species (ROS) acting as second messengers and damaging macromolecules, control cell death through permeability transition pore opening and cytochrome c release initiating apoptosis, perform beta-oxidation of fatty acids, amino acid catabolism, haem biosynthesis, and steroidogenesis. Mitochondria are semi-autonomous organelles with their own 16.5 kb circular genome (mtDNA) encoding 13 OXPHOS subunits, 22 tRNAs, and 2 rRNAs.

Mitochondria are descended from alpha-proteobacterial endosymbionts—engulfed by a proto-eukaryotic host over 1.5 billion years ago in the endosymbiotic event responsible for the eukaryotic cell's ability to exploit aerobic respiration. Over evolutionary time most ancestral bacterial genes transferred to the nuclear genome, leaving mtDNA as a minimal encoding genome. Human mtDNA exists at 500-1000 copies per cell (polyploidy unique among human DNA) and is exclusively maternally inherited. Mitochondrial heteroplasmy—mixtures of wild-type and mutant mtDNA in a cell—determines disease penetrance when pathogenic mutations are present.

Oxidative Phosphorylation

Electron Transport Chain

The electron transport chain (ETC) comprises five multiprotein complexes embedded in the inner mitochondrial membrane. Complex I (NADH ubiquinone oxidoreductase, 45 subunits): accepts electrons from NADH, transfers to ubiquinone, pumping 4 H+ per 2e-. Complex II (succinate dehydrogenase): transfers electrons from FADH2 to ubiquinone without H+ pumping. Complex III (cytochrome bc1): transfers electrons from ubiquinol to cytochrome c pumping 4 H+ via Q-cycle. Complex IV (cytochrome c oxidase): transfers electrons from cytochrome c to O2 reducing to water, pumping 2 H+ per 2e-. Complex V (ATP synthase): uses the proton gradient (proton motive force) generated by complexes I, III, IV to phosphorylate ADP to ATP—the chemiosmotic theory (Mitchell, Nobel 1978).

Reactive Oxygen Species

Electrons leaking from the ETC (mostly at complex I and III) react with O2 producing superoxide (O2•-)—converted to H2O2 by MnSOD (mitochondrial matrix) or CuZnSOD (cytoplasm). H2O2 is detoxified by catalase, glutathione peroxidase, and peroxiredoxins. At controlled levels, mitochondrial ROS act as signalling molecules activating HIF-1alpha (through prolyl hydroxylase inhibition), NF-kB, and autophagy. At elevated levels (from ETC dysfunction, mitochondrial membrane potential changes, or antioxidant depletion) ROS damage proteins, lipids, and mtDNA causing mitochondrial dysfunction. Paradoxically, mild ROS increases (mitohormesis) extend lifespan in C. elegans through adaptive stress response; excessive ROS damage drives ageing.

Mitochondrial Dynamics

Fusion and Fission

Mitochondria are not static—they continuously fuse and divide (mitochondrial dynamics) in response to metabolic state and stress. Fusion: outer membrane fusion by Mitofusin1/2 (MFN1/2) GTPases; inner membrane fusion by OPA1. Fission: DRP1 GTPase is recruited to mitochondrial constriction sites by FIS1, MFF, and MIEF adaptors, forming spiralling rings that pinch off mitochondria. Fusion enables complementation of damaged mtDNA and proteins between organelles; fission enables mitophagy of damaged mitochondria, asymmetric partitioning during cell division, and mitochondrial trafficking. DRP1 mutations cause neonatal encephalopathy; OPA1 mutations cause dominant optic atrophy (vision loss). Cancer cells often show hyperfused mitochondrial networks resisting apoptosis.

Mitophagy

Mitophagy is selective autophagy removing damaged mitochondria. PINK1 (mitochondrial kinase) is constitutively imported and degraded in healthy mitochondria; in damaged mitochondria with reduced membrane potential, PINK1 accumulates on the outer membrane, phosphorylating ubiquitin chains. Phospho-ubiquitin recruits Parkin (E3 ubiquitin ligase) which ubiquitinates outer membrane proteins; ubiquitin-binding autophagy receptors (OPTN, NDP52) link ubiquitinated mitochondria to LC3k+ autophagosomes for lysosomal degradation. Mutations in PINK1 and Parkin cause early-onset Parkinson's disease, establishing defective mitophagy—accumulation of damaged mitochondria—as a pathogenic mechanism in neurodegeneration.

Mitochondria and Cell Death

Mitochondria are central to intrinsic apoptosis. Pro-apoptotic BCL-2 family members (BAX, BAK) oligomerise at the outer mitochondrial membrane forming pores causing MOMP (mitochondrial outer membrane permeabilisation)—releasing cytochrome c, Smac/DIABLO, and AIF to the cytoplasm. Cytochrome c assembles with APAF-1 and procaspase-9 forming the apoptosome, activating caspase-9 which cleaves and activates executioner caspases-3 and 7. BCL-2, BCL-xL, MCL-1 (anti-apoptotic proteins) prevent MOMP by sequestering BAX/BAK. Venetoclax (BCL-2 inhibitor) achieves high remission rates in CLL by enabling MOMP in cancer cells dependent on BCL-2 for survival, demonstrating mitochondrial apoptosis as a druggable cancer vulnerability.

Examples and Applications

Example 1: Venetoclax in Haematological Cancers

BCL-2 is the archetypical anti-apoptotic protein, first discovered at the t(14;18) chromosomal translocation breakpoint in follicular lymphoma placing it under immunoglobulin heavy chain enhancer control. Venetoclax directly inhibits BCL-2 by occupying its hydrophobic groove, displacing sequestered BAX/BAK which oligomerise and cause MOMP. In CLL, venetoclax + ibrutinib achieves >90% complete remission with undetectable MRD at fixed treatment duration in clinical trials. In AML with IDH mutations or NPM1 mutations, venetoclax + azacitidine achieved 74% overall response—transforming outcomes for elderly patients who cannot tolerate intensive chemotherapy.

Example 2: Mitochondrial Gene Therapy

Mitochondrial diseases from mtDNA mutations are challenging for gene therapy because mtDNA is inside the mitochondrial matrix—hard to access with conventional vectors. Approaches include nuclear transgene expression of mitochondrially targeted corrective genes (allotopic expression); mtDNA base editing using mitoTALEs and mitoZFNs to selectively eliminate mutant mtDNA heteroplasmy by cutting only the mutant sequence. GenSight Biologics' GS010 delivers ND4 gene to retinal ganglion cells for LHON (ND4 point mutation), improving visual acuity in clinical trials. MitoTALEN/mtZFN approaches shifting heteroplasmy toward wild-type are in preclinical development for common mtDNA mutations.

Example 3: PINK1/Parkin Pathway in Parkinson's

Autosomal recessive Parkinson's disease mutations in PINK1 and PARKIN impair mitophagy, cause mitochondrial dysfunction, and ultimately dopaminergic neuron death. Animal models (Drosophila, mouse) with PINK1/Parkin deletion show mitochondrial morphology defects and neurodegeneration. Exercise activates BNIP3L/NIX-mediated mitophagy providing neuroprotective effects—epidemiologically supported by exercise reducing PD risk 30-40%. NAD+ precursors restoring mitophagy efficiency, mTOR inhibition increasing autophagy, and mitochondria-targeted antioxidants (MitoQ) are being tested in PD patients and models as mitophagy-enhancing strategies.

Example 4: Mitochondrial Transfer Therapy

Tunnelling nanotubes between cells enable natural mitochondrial transfer—a rescue mechanism observed in cardiac and airway cells. Therapeutic mitochondrial transfer from healthy cells to damaged cells is being explored: transfer of healthy mitochondria to ischaemically damaged cardiac cells post-MI restored mitochondrial function and improved recovery in animal models. A 2016 clinical report described hand-transplanted mitochondria administration during paediatric cardiac surgery, with apparent functional improvement. Cell-derived mitochondrial transplantation for mitochondrial disease is in early clinical development; challenges include efficient delivery, immune response, and quantitative evaluation.

Example 5: Warburg Effect and Cancer Metabolism

Cancer cells preferentially use glycolysis even in the presence of oxygen (Warburg effect), generating lactate rather than fully oxidising glucose in mitochondria. Warburg proposed that mitochondrial damage drove this metabolic shift; modern understanding clarifies that many cancer cells have intact mitochondria but metabolically reprogram to support biosynthesis. Glutamine is the primary TCA anaplerosis substrate in many cancers—CB-839 (glutaminase inhibitor) targeted cancer glutamine dependency. Lactate secretion by cancer cells acidifies the tumour microenvironment suppressing immune cell activity; sodium-bicarbonate supplementation or MCT4 inhibition targeting lactate export are therapeutic strategies modulating tumour immunosuppressive acidity.

Example 6: Mitochondria and Immunity

Mitochondria serve as platforms for innate immune signalling. MAVS (mitochondrial antiviral signalling protein) on the outer mitochondrial membrane is activated by RIG-I sensing viral RNA, forming functional prion-like aggregates propagating signalling. Damaged mtDNA released to the cytoplasm activates cGAS-STING innate immune sensing. NLRP3 inflammasome activation requires both TLR priming and a second signal including mitochondrial ROS or cytoplasmic mtDNA. Impaired mitophagy in macrophages leads to mtDNA release activating STING and driving systemic lupus erythematosus-like inflammatory disease in mice—establishing mitophagy as a regulator of innate immune activation and autoimmunity.

Example 7: Mitochondria in Brown Adipose Tissue

Brown adipose tissue (BAT) mitochondria are unique—extraordinarily abundant (BAT cells look brown from their density), with uncoupling protein UCP1 in the inner mitochondrial membrane creating a proton leak bypassing ATP synthase and dissipating the proton gradient as heat. Cold exposure activates sympathetic nerves; noradrenaline via beta-3 adrenergic receptor activates cAMP-PKA, phosphorylating lipases releasing fatty acids that both fuel and directly activate UCP1. BAT thermogenesis in human adults (PET scan detectable as FDG-avid tissue in the neck) provides up to 400 kcal/day heat in cold—relevant for metabolic disease. BAT activation pharmacologically is a target for obesity treatment.

Example 8: Mitochondrial Maternal Inheritance and Phylogenetics

Mitochondrial DNA is exclusively maternally inherited in humans (paternal mitochondria are actively eliminated in the fertilised egg through PINK1/Parkin-mediated mitophagy). This matrilineal inheritance and lack of recombination make mtDNA a powerful molecular clock for human population genetics. Mitochondrial haplogroups—defined by specific mtDNA mutations accumulating along maternal lineages—track human migration out of Africa (~180,000 years ago), populating Eurasia via both northern and southern routes, and into the Americas (around 15,000 years ago). The 'mitochondrial Eve' concept—the most recent common matrilineal ancestor of all humans—places her in Africa approximately 150,000-200,000 years ago based on mtDNA phylogenetics.

Try it live

Everything above runs in your browser — open Mitochondria Biology: Energy, Signalling, and Disease and change the parameters while it is running. Nothing is installed, nothing is uploaded, the whole model lives in one tab.